The actual role of SARS‐CoV‐2 in brain damage remains controversial due to lack of
matched controls. We aim to highlight to what extent is neuropathology determined by SARS …

Background This study examined neuropathological findings of patients who died following
hospitalization in an intensive care unit with SARS-CoV-2. Methods Data originate from 20 …

Abstract SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2), the new
coronavirus responsible for the pandemic disease in the last year, is able to affect the central …

Infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily
lead to upper respiratory tract infection and its sequelae frequently dominate the clinical …

Background and purpose Neuropathological studies can elucidate the mechanisms of
nervous system damage associated with SARS‐CoV‐2 infection. Despite literature on this …

Background: Neuroinvasive properties of SARS-CoV-2 have allowed the hypothesis of
several pathogenic mechanisms related to acute and chronic neurological sequelae …

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread worldwide and has had …

Increasing evidence suggests that infection with Sars-CoV-2 causes neurological deficits in
a substantial proportion of affected patients. While these symptoms arise acutely during the …

Many patients with SARS-CoV-2 infection develop neurological signs and symptoms;
although, to date, little evidence exists that primary infection of the brain is a significant …

Background Prominent clinical symptoms of COVID-19 include CNS manifestations.
However, it is unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV …